tetano
Editor, Senior Moderator
Future Microbiol. 2019 Sep 9. doi: 10.2217/fmb-2019-0203. [Epub ahead of print]
[h=1]The challenges of influenza for public health.[/h] ?lvarez F[SUP]1[/SUP], Froes F[SUP]2[/SUP], Rojas AG[SUP]3[/SUP], Moreno-Perez D[SUP]4,[/SUP][SUP]5[/SUP], Martin?n-Torres F[SUP]6,[/SUP][SUP]7[/SUP].
[h=3]Author information[/h] 1 Health Center of Llanera (Asturias), Medicine Department, University of Oviedo, Asturias, Spain. 2 Intensive Care Unit, Hospital Pulido Valente, Centro Hospitalar Lisboa Norte, Lisbon, Portugal. 3 Asociaci?n Espa?ola de Vacunolog?a (AEV), Spain. 4 Department of Pediatrics, Pediatric Infectology & Immunodeficiency Unit, Regional University Children?s Hospital of Malaga, Malaga, Spain. 5 IBIMA Multidisciplinary Group for Pediatric Research of Malaga, Malaga University, Malaga, Spain. 6 Department of Paediatrics, Translational Paediatrics & Infectious Diseases, Hospital Cl?nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain. 7 Instituto de Investigaci?n Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
[h=3]Abstract[/h] Influenza, an infectious disease of the respiratory system, represents a major burden for public health. This disease affects all age groups with different prognosis, being life threatening for vulnerable individuals. Despite influenza being a vaccine-preventable disease, the control of the infection needs annual vaccination campaigns and constant improvements. Herein, the main challenges of influenza in relation to the pathogenic agent, the available vaccines and the health impact identified during the Light on Vax event, an expert meeting organized by the Asociaci?n Espa?ola de Vacunolog?a [Spanish Vaccinology Association] (AEV), are reported. Further possible steps in the control of influenza are also suggested. Ideally, the development of innovative and universal vaccines that would confer life-lasting and broader-spectrum immunity is highly desirable.
[h=4]KEYWORDS:[/h] annual vaccination; influenza; influenza virus; quadrivalent vaccine; risk group; trivalent vaccine; vaccine-preventable disease
PMID: 31498705 DOI: 10.2217/fmb-2019-0203
[h=1]The challenges of influenza for public health.[/h] ?lvarez F[SUP]1[/SUP], Froes F[SUP]2[/SUP], Rojas AG[SUP]3[/SUP], Moreno-Perez D[SUP]4,[/SUP][SUP]5[/SUP], Martin?n-Torres F[SUP]6,[/SUP][SUP]7[/SUP].
[h=3]Author information[/h] 1 Health Center of Llanera (Asturias), Medicine Department, University of Oviedo, Asturias, Spain. 2 Intensive Care Unit, Hospital Pulido Valente, Centro Hospitalar Lisboa Norte, Lisbon, Portugal. 3 Asociaci?n Espa?ola de Vacunolog?a (AEV), Spain. 4 Department of Pediatrics, Pediatric Infectology & Immunodeficiency Unit, Regional University Children?s Hospital of Malaga, Malaga, Spain. 5 IBIMA Multidisciplinary Group for Pediatric Research of Malaga, Malaga University, Malaga, Spain. 6 Department of Paediatrics, Translational Paediatrics & Infectious Diseases, Hospital Cl?nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain. 7 Instituto de Investigaci?n Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
[h=3]Abstract[/h] Influenza, an infectious disease of the respiratory system, represents a major burden for public health. This disease affects all age groups with different prognosis, being life threatening for vulnerable individuals. Despite influenza being a vaccine-preventable disease, the control of the infection needs annual vaccination campaigns and constant improvements. Herein, the main challenges of influenza in relation to the pathogenic agent, the available vaccines and the health impact identified during the Light on Vax event, an expert meeting organized by the Asociaci?n Espa?ola de Vacunolog?a [Spanish Vaccinology Association] (AEV), are reported. Further possible steps in the control of influenza are also suggested. Ideally, the development of innovative and universal vaccines that would confer life-lasting and broader-spectrum immunity is highly desirable.
[h=4]KEYWORDS:[/h] annual vaccination; influenza; influenza virus; quadrivalent vaccine; risk group; trivalent vaccine; vaccine-preventable disease
PMID: 31498705 DOI: 10.2217/fmb-2019-0203